• Mashup Score: 0

    1800 M Street NW, Suite 1050 South,Washington, DC 20036Phone: (202) 944-6700Friends of Cancer Research is a 501 (C)(3) non-profit organization.Our tax ID number is 52-1983273. About Careers Contact Donate Glossary of Terms Privacy Policy Policy on Corporate Partnerships Terms & Conditions Media…

    Tweet Tweets with this article
    • Friends has been leading projects on real-world evidence #RWE since 2018. During our public meeting on Sept. 11, leaders in the field will discuss the strengths & future implications of real-world data in #oncology drug development. Register here: https://t.co/NNfl11ReCV https://t.co/hXVYDVYlrN

  • Mashup Score: 0
    DIA 2023 - 10 month(s) ago

    For more than 50 years, DIA has provided the world’s largest global, neutral stage for life science professionals to come together and address healthcare challenges. Driven by purpose and focused on the future of health, the stakeholders who gather at our Global Annual Meeting advance science and technology for public health impact – today, and for generations to come.

    Tweet Tweets with this article
    • @CancerResrch's @md_stewart is speaking live @DrugInfoAssn #DIA2023 about Friends #RWE Project. Click to learn more and tune in! https://t.co/2ai8O8GkG8 https://t.co/BwS5qGlB5o

  • Mashup Score: 2

    This study uses results from randomized clinical trials as a reference to learn whether similar clinical conclusions could be drawn had the RCT protocol been translated and implemented as a database study protocol.

    Tweet Tweets with this article
    • Do observational studies using real world evidence #RWE from payor claims reach similar conclusions as randomized clinical trials? This well-designed, systematic study (RCT-DUPLICATE) in @JAMA_current tells us that the answer is . . . . complex. https://t.co/yd4l4wWuxk

  • Mashup Score: 0

    Quick Links Sign Up for Updates RWE Portfolio One-Pager rw-Response Project Powerpoint Project Outcomes ASCO Annual Meeting Poster The Friends of Cancer Research Real-World Evidence portfolio develops and establishes methodology for using RWD to demonstrate benefit to patients. Visit us on LinkedIn and Twitter to stay up to date with #RWEFriends. What is the unmet need and why does it…

    Tweet Tweets with this article
    • Friends #RWE portfolio develops and establishes methodology for using RWD to demonstrate benefit to #patients. Stay up to date with #RWEFriends projects: https://t.co/RGNPWfLlHY

  • Mashup Score: 0

    AuthorsBrittany Avin McKelveyFriends of Cancer Research, Washington, DCBrittany Avin McKelvey, Elizabeth Garrett-Mayer, Andrew J. Belli, Thomas D. Brown, Jessica Dow, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi Shruti Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Donna Rivera, Hillary Stires, Mark Stewart, Jeff Allen, Janet L. EspiritoOrganizationsFriends of Cancer Research, Washington,…

    Tweet Tweets with this article
    • @CancerResrch is sharing new #RWE pilot results assessing a measure of rw-response across datasets. Come see the poster! 1:15 PM - 4:15 PM CDT @ASCO #ASCO23: https://t.co/orOaxD2lo0 #RWEFriends https://t.co/78aiLAzaZ0

  • Mashup Score: 0

    AuthorsBrittany Avin McKelveyFriends of Cancer Research, Washington, DCBrittany Avin McKelvey, Elizabeth Garrett-Mayer, Andrew J. Belli, Thomas D. Brown, Jessica Dow, Janet L. Espirito, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi Shruti Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Donna Rivera, Hillary Stires, Mark Stewart, Jeff AllenOrganizationsFriends of Cancer Research, Washington,…

    Tweet Tweets with this article
    • @CancerResrch is sharing a new #RWE pilot assessing a measure of rw-response across datasets tomorrow! Come see the poster from 1:15 PM - 4:15 PM CDT @ASCO #ASCO23: https://t.co/i1nk1qHM1X #RWEFriends https://t.co/cgZd8vnAmO